| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From Spectra Biomedical, Inc., Menlo Park, CA.
Address correspondence and reprint requests to Dr. Stephen J. Peroutka, Spectra Biomedical, Inc., 4040 Campbell Avenue, Menlo Park, CA 94025.
This review summarizes a growing body of biological, pharmacologic, and genetic data that support a role for dopamine in the pathophysiology of certain subtypes of migraine. Most migraine symptoms can be induced by dopaminergic stimulation. Moreover, there is dopamine receptor hypersensitivity in migraineurs, as demonstrated by the induction of yawning, nausea, vomiting, hypotension, and other symptoms of a migraine attack by dopaminergic agonists at doses that do not affect nonmigraineurs. Conversely, dopamine receptor antagonists are effective therapeutic agents in migraine. Recent genetic data suggest that molecular variations within dopamine receptor genes play a modifying role in the pathophysiology of migraine with aura. Therefore, modulation of dopaminergic neurotransmission should be considered in the therapeutic management of migraine.
Received December 30, 1996. Accepted in final form March 11, 1997.
This article has been cited by other articles:
|
|
 |
|
  A. R Charbit, S. Akerman, and P. J Goadsby Comparison of the Effects of Central and Peripheral Dopamine Receptor Activation on Evoked Firing in the Trigeminocervical Complex J. Pharmacol. Exp. Ther., November 1, 2009; 331(2): 752 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Charbit, S. Akerman, P. R. Holland, and P. J. Goadsby Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study J. Neurosci., October 7, 2009; 29(40): 12532 - 12541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Levy, M. S. Matharu, K. Meeran, M. Powell, and P. J. Goadsby The clinical characteristics of headache in patients with pituitary tumours Brain, August 1, 2005; 128(8): 1921 - 1930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Akerman and P. J. Goadsby The Role of Dopamine in a Model of Trigeminovascular Nociception J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 162 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Hershey and P. K. Winner Pediatric Migraine: Recognition and Treatment J Am Osteopath Assoc, April 1, 2005; 105(4_suppl): 2S - 8S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Melliti, M. Grabner, and G. R Seabrook The familial hemiplegic migraine mutation R192q reduces G-protein-mediated inhibition of p/q-type (Cav2.1) calcium channels expressed in human embryonic kidney cells J. Physiol., January 15, 2003; 546(2): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M F P Peres, M S. del Rio, M L V Seabra, S Tufik, J Abucham, J Cipolla-Neto, S D Silberstein, and E Zukerman Hypothalamic involvement in chronic migraine J. Neurol. Neurosurg. Psychiatry, December 1, 2001; 71(6): 747 - 751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Kabbouche, A.-L. B. Vockell, S. L. LeCates, S. W. Powers, and A. D. Hershey Tolerability and Effectiveness of Prochlorperazine for Intractable Migraine in Children Pediatrics, April 1, 2001; 107(4): e62 - e62. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Neuhauser, M. Leopold, M. von Brevern, G. Arnold, and T. Lempert The interrelations of migraine, vertigo, and migrainous vertigo Neurology, February 27, 2001; 56(4): 436 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.M. Mulleners, E.P. Chronicle, J.E. Palmer, P.J. Koehler, and J.W. Vredeveld Suppression of perception in migraine: Evidence for reduced inhibition in the visual cortex Neurology, January 23, 2001; 56(2): 178 - 183. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
